QUALITY OF LIFE OF PATIENTS WITH OVARIAN CANCER OF THE THIRD STAGE USING DIFFERENTIATED TREATMENT

Andriy Rybin

Abstract


The aim of this research was to assess the quality of life in patients with stage III ovarian cancer during the treatment period, depending on the applied therapeutic approaches.

A comparative analysis of the results of treatment of 350 patients with adenocarcinoma of the ovaries of III-IV stage, which have undergone suboptimal or non-optimal cytomelective surgery, was conducted. To assess the quality of life and to examine the relationship between changes in physical health and quality of life, patients in both groups were asked to complete the questionnaires EORTC QLQ-C30 and SF-36. According to the questionnaire of the EORTC QLQ-C30, the indicators of physical activity, the ability to do everyday affairs, were higher in the second group of patients who received differentiated treatment. The indicator of "social functioning" was also higher in the II group of patients. When evaluating the patients' liver on the scale of the questionnaire SF-36, it was found that the positive effect of differentiated therapy is maintained for 3 years. Life quality is an important criterion for evaluating the results of antitumor therapy, and when it is continuously monitored in patients with ovarian cancer the safety of treatment for patients could be improved, including at an advanced stage

Keywords


ovarian cancer; treatment; prognostication; quality of life

Full Text:

PDF

References


Hvastunov, R. A., Stolorenko, V. V., Lyutaya, E. D., Devyatchenko, T. F., Egin, E. I. (2004). Diagnosticheskie algoritmyi kompleksnogo monitoringa pri spetsialnom lechenii rasprostranennogo raka yaichnikov. Sovremennaya onkologiya, 6 (1), 11–16.

Tyulyandin, S. A. (1999). Vyibor himioterapii pervoy linii u bolnyih rasprostranennyim rakom yaichnikov. Voprosyi onkologii, 4, 350–354.

Shinde, S., Wanger, T., Novotny, P., Grudem, M., Jatoi, A. (2015). Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series. European Journal of Gynaecological Oncology, 36 (2), 155–160.

Doll, K. M., Pinheiro, L. C., Reeve, B. B. (2017). Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: A SEER-MHOS study. Gynecologic Oncology, 144 (2), 348–353. doi: 10.1016/j.ygyno.2016.12.005

Di Maio, M., Perrone, F. (2016). Lessons from clinical trials on quality-of-life assessment in ovarian cancer trials. Annals of Oncology, 27 (6), 961–962. doi: 10.1093/annonc/mdw153

Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J. et. al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88 (11), 815–823. doi: 10.2471/blt.09.067231

Zhurman, V. N., Eliseeva, E. V., Gulevich, A. P., Volkov, M. V. (2016). Otsenka kachestva zhizni bolnyih rakom yaichnikov I-III stadii po obschemu oprosniku EQ-5D i spetsialnomu oprosniku EORTC QLQ-C30. Kachestvennaya klinicheskaya praktika, 2, 46–51.

Zhou, Y., Irwin, M. L., Ferrucci, L. M., McCorkle, R., Ercolano, E. A., Li, F. et. al. (2016). Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors – I. Gynecologic Oncology, 141 (3), 543–549. doi: 10.1016/j.ygyno.2016.04.006

Halafyan, A. A. (2008). Statistica 6. Statisticheskiy analiz dannyih. Moscow: OOO «Binom-Press», 512.

Ahmed-Lecheheb, D., Joly, F. (2016). Ovarian cancer survivors’ quality of life: a systematic review. Journal of Cancer Survivorship, 10 (5), 789–801. doi: 10.1007/s11764-016-0525-8

Thaker, P. H., Sereika, S. M., Arida, J., Edwards, R. P., Donovan, H. (2015). A comparison of monthly symptom reports for older (≥ 70 years) versus younger (< 70 years) women with recurrent ovarian cancer over 1 year. Journal of Clinical Oncology, 33(29), 85. doi: 10.1200/jco.2015.33.29_suppl.85

Ledermann, J. A., Harter, P., Gourley, C., Friedlander, M., Vergote, I. B., Rustin, G. J. S. et. al. (2014). 885pdhealth-related quality of life (hrqol) during olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (psr soc) and a brca mutation (brcam). Annals of Oncology, 25 (4), 308–309. doi: 10.1093/annonc/mdu338.11

Phippen, N. T., Secord, A. A., Wolf, S., Samsa, G., Davidson, B., Abernethy, A. P. et. al. (2017). Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study. Gynecologic Oncology. doi: 10.1016/j.ygyno.2017.07.121

Colombo, N., Lorusso, D., Scollo, P. (2017). Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future. International Journal of Gynecological Cancer, 27 (6), 1134–1140. doi: 10.1097/igc.0000000000001023

Roncolato, F. T., Gibbs, E., Lee, C. K., Asher, R., Davies, L. C., Gebski, V. J. et. al. (2017). Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy. Annals of Oncology, 28 (8), 1849–1855. doi: 10.1093/annonc/mdx229

Lutgendorf, S. K., Shinn, E., Carter, J., Leighton, S., Baggerly, K., Guindani, M. et. al. (2017). Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach. Gynecologic Oncology, 146 (1), 101–108. doi: 10.1016/j.ygyno.2017.05.008

Bhugwandass, C. S., Pijnenborg, J. M. A., Pijlman, B., Ezendam, N. P. M. (2016). Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry. Current Oncology, 23 (6), 556–562. doi: 10.3747/co.23.3243

King, M. T., Stockler, M. R., Butow, P., O’Connell, R., Voysey, M., Oza, A. M. et. al. (2014). Development of the Measure of Ovarian Symptoms and Treatment Concerns. International Journal of Gynecological Cancer, 24 (5), 865–873. doi: 10.1097/igc.0000000000000167

Lawrie, T. A., Winter-Roach, B. A., Heus, P., Kitchener, H. C. (2015). Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd004706.pub5

Dubinina, V. H., Rybin, A. I. (2016). Yakist zhyttia khvorykh na rak yaiechnykiv yak indykator funktsionalnoi otsinky efektyvnosti adiuvantnoi platynovoi khimioterapii. Visnyk morfolohii, 22 (2), 328–331.




DOI: http://dx.doi.org/10.21303/2504-5679.2017.00405

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 Andriy Rybin

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)